Furthermore, Cyr61 has highlighted the pivotal role this molecule can play in regulating the immune-surveillance process and it has emerged as an important partner when targeting components of the infectious or chronic inflammatory disease processes such as atherosclerosis or rheumatoid arthritis [3–5]. Here, CCN1 is linked to atherosclerosis.